Four Skolkovo biomed startups have obtained sponsorship from Johnson & Johnson, and met with the U.S. multinational’s executive vice president and chief scientific officer Paul Stoffels during his recent visit to the innovation centre. Skolkovo...
Skolkovo resident 3D Bioprinting Solutions made headlines around the world in 2015 when it printed a functioning thyroid construct and transplanted it successfully into a mouse. Now it looks set to make history again by sending a bioprinter into space. 3D...
In a year in which supercomputer capacity records are sure to be smashed once again, the European Union has already said it will spend 1 billion euros this year on the machines, which can be used to calculate anything from weather forecasts and oil and gas...
The Skolkovo Foundation has joined forces with the U.K.’s AMR Centre, a private-public initiative launched in 2016 to support and accelerate the development of new antibiotics, to combat the global problem of antimicrobial resistance. Skolkovo's...
Russia’s first commercial research biobank, National BioService , opened a brand new laboratory at the Skolkovo Technopark on Thursday. The National BioService lab at the Skolkovo Technopark will be used for both the company's own research and...
Insilico Medicine , the parent company of Skolkovo resident biomed startup Insilico , has published a peer-review research paper calling for patients to regain control of their personal medical records, and even to profit from them. The Baltimore-based Insilico...
The first shared lab space in Russia for life sciences and biotech startups opened its doors at the Skolkovo Technopark on Wednesday with a mission to help budding biomed entrepreneurs test their theories and turn their ideas into a commercial company. ...
Russia’s official position on the potentially lucrative field of asteroid mining is that it is outlawed by the 1967 Outer Space Treaty, which declares that space is “the province of mankind,” and that its use and exploration must “benefit...
Pharm-Sintez.Lab , a resident startup of the Skolkovo Foundation’s nuclear cluster, has developed a system for detecting rare forms of cancer in Russian patients. Lev Voloznev, CEO of Pharm-Sintez.Lab, pictured in his lab at the Skolkovo Technopark...
Scientists, tech entrepreneurs, students, professors and all other members of the Skolkovo innovation ecosystem now have access to the goldmine of scientific information compiled by the Elsevier publishing house. The Elsevier publishing house produces...
Russia’s wealth of fossil fuel resources has inevitably made it easy for the country to ignore renewable energy sources (RES). In recent years, however, several government initiatives have been launched to develop this sector, and at the REENCON-21 International...
Skolkovo startup DRD Biotech has produced a working prototype of an express test that can determine in just a few minutes whether a person has had – or is at near-term risk of having – the most common kind of stroke. Svetlana Dambinova has...
ExoAtlet , a Skolkovo startup that makes medical exoskeletons for the rehabilitation of disabled people, has started clinical research into the use of its exoskeletons to help people with multiple sclerosis. An ExoAtlet exoskeleton being demonstrated...
3D Bioprinting Solutions , a resident company of the Skolkovo Foundation that made headlines last year when it printed the world’s first functional thyroid construct for a mouse, is to make a 3D bioprinter for printing tissue and organ constructs on board...
If scientists invented an anti-ageing pill that would help you live to the age of 120, would you take it? Think carefully, because if it sounds like science fiction, it’s not. Ageing is a treatable disease like any other, according to some scientists...
As the world discusses the ethics of growing human organs in pigs , scientists gathered at the Skolkovo Foundation last week to discuss an equally divisive topic: that of human genome modification. Scientists in the U.S. are currently making headlines...
Napoleon once allegedly described England as a nation of shopkeepers, but if he were around today, he would say the U.K. is a nation of small and medium enterprises (SMEs), according to U.K. clinical research expert Dr. Ignazio di Giovanna. Jonathan Brenton...
A 3D printer for use in space is the end goal of a joint project between two residents of the Skolkovo Foundation – the companies Sputnix and Anisoprint – and Moscow Polytechnic University. Fyodor Antonov, director of Anisoprint., a resident...
One of Russia’s largest manufacturers of electricity generators and electric motors is to form a research center at Skolkovo under an agreement worth 280 million rubles and signed at Startup Village this week. Grachev, right, and Shcherbakov at...
Prime Minister Dmitry Medvedev says Skolkovo is starting to produce tangible results, despite being less than five years old. From left: Skolkovo president Victor Vekselberg, his advisor Pekka Viljakainen, and Prime Minister Medvedev. Photo: sk.ru ...
A major investment fund that provides the government with technology solutions in the energy industry is to base its research center at Skolkovo under a deal signed at Startup Village this week. The signing ceremony at Startup Village. Photo: sk.ru ...
A new 3D face recognition system developed by Skolkovo IT cluster resident Vocord FaceControl has proved flawless in testing, the company says. The biometric face recognitions system Vocord FaceControl 3D is built upon 3D machine vision, and during testing...
Skolkovo biomed cluster resident 3D Bioprinting Solutions has announced the successful printing of a mouse’s thyroid gland. 3D Bioprinting Solutions unveiled Russia's first bioprinter in October. Photo: 3D Bioprinting Solutions If confirmed...
Skolkovo resident biomed company Aelita has put a new anesthetic machine through five months of successful testing on real patients, passing a key test on the path to market entry. The machine, known as Anekom, is intended for inhalation anesthesia in combination...
A 30 million ruble grant from the Skolkovo Foundation is helping a team of Russian scientists develop potentially one of the most effective drugs yet to fight cardiovascular disease – the primary cause of death in Russia and the wider world. Dmitry...